Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
55 studies found for:    "Coccidioidomycosis"
Show Display Options
Rank Status Study
1 Completed Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Conditions: Coccidioidomycosis;   Rheumatoid Arthritis
2 Not yet recruiting Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention: Drug: Sertraline
3 Completed
Has Results
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
Condition: Coccidioidomycosis
Interventions: Drug: Posaconazole;   Drug: Fluconazole
4 Completed A Multi-center Study of Spherule-Derived Coccidioidin
Condition: Coccidioidomycosis
Intervention: Biological: Spherule-derived coccidioidin
5 Completed A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
Conditions: Mycoses;   HIV Infections;   Coccidioidomycosis
Intervention: Drug: Fluconazole
6 Recruiting Early Fluconazole Treatment for Coccidiodomycosis Pneumonia
Condition: Coccidioidomycosis
Interventions: Other: Placebo;   Drug: Fluconazole
7 Completed Rift Valley Fever in Kenya
Condition: Rift Valley Fever
8 Recruiting Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Condition: Coccidioidomycosis
9 Completed Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
Condition: Rift Valley Fever
Intervention: Biological: RVF MP-12
10 Completed Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
11 Enrolling by invitation Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
12 Terminated Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
Condition: Coccidioidomycosis
Intervention: Drug: nikkomycin Z
13 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
14 Recruiting Lyon Cohort of Maternal and Congenital Toxoplasma Infections
Condition: Toxoplasmosis, Congenital
15 Not yet recruiting Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Conditions: Toxoplasmosis Infection;   Genotype II;   Ocular Toxoplasmosis With Recurrences
Intervention: Biological: seropositive for Toxoplasma gondii
16 Completed Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
Condition: Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection
Interventions: Other: Fluorescein angiography;   Other: Dilated fundus examination;   Biological: Toxoplasmosis serology;   Drug: Anti-toxoplasmosis treatment;   Drug: Anti-inflammatory treatments;   Other: Puncture in anterior chamber
17 Recruiting Cryptosporidiosis and Enteropathogens in Bangladesh
Condition: Cryptosporidiosis
18 Active, not recruiting Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia
Conditions: Toxoplasmosis;   Schizophrenia
Interventions: Drug: Sodium Valproate treatment;   Drug: Placebo
19 Active, not recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
20 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years